Clincosm LogoSign in Get a demo

monoclonal gammopathy of undetermined significance (mgus)

Showing 1 - 4 of 4
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Monoclonal Gammopathy of Undetermined Significance (MGUS), Smoldering Multiple Myeloma (SMM) Trial (Linvoseltamab)

Not yet recruiting
  • Monoclonal Gammopathy of Undetermined Significance (MGUS)
  • Smoldering Multiple Myeloma (SMM)
  • (no location specified)
Nov 17, 2023

A Cohort Study of Plasma Cell Disorders (PCDs) in PKUFH

Recruiting
  • Multiple Myeloma
  • +11 more
  • No intervention
  • Beijing, China
    Peking University First Hospital
Apr 21, 2022

MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular

Recruiting
  • Monoclonal Gammopathy of Undetermined Significance (MGUS)
  • +8 more
    • Boston, Massachusetts
    • +6 more
    Apr 14, 2022

    The Development and Pilot Testing ofNew MR Imaging Protocol to

    Completed
    • Myeloma
    • +2 more
    • Diffusion Weighted Magnetic Resonance Imaging (DWMRI)
    • +2 more
    • Oxford, Oxfordshire, United Kingdom
      Churchill Hospital
    Feb 4, 2021